Gammagard Liquid 10%: Completed Phase III enrollment

Baxter completed enrollment of 40 patients in a double-blind, placebo-controlled, crossover, international Phase III trial of IV Gammagard Liquid 10%. Gammagard has Orphan Drug designation in the U.S....